4/A: Alphatec Holdings Director Paul Segal Sells 100,000 Shares, Corrects Previous Filing

Paul Segal, a director at Alphatec Holdings, sold 100,000 shares of common stock at $16.15 per share on June 15, 2023, according to an amended SEC Form 4 filing.

Summary

• This is an amended SEC Form 4 filing by Paul Segal, a director at Alphatec Holdings, Inc.
• The amendment corrects an error in the original Form 4 filed on June 16, 2023.
• On June 15, 2023, Segal sold 100,000 shares of Alphatec Holdings common stock.
• The sale price was $16.15 per share.
• Following the transaction, Segal directly owns zero shares.
• Segal may be deemed to have shared beneficial ownership of 11,081,538 shares held by L-5 Healthcare Partners, LLC, due to his position as manager of L-5.
• Segal disclaims beneficial ownership of these shares except to the extent of his indirect pecuniary interest.
• The filing indicates that the transaction was not made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a stock sale. It doesn't inherently convey positive or negative sentiment about the company's prospects.

Management Comments

• Mr. Segal disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider and provides transparency to the market regarding the insider's holdings and transactions in the company's stock.

Stakeholder Impact

• The stock sale by a director could be perceived negatively by some shareholders, but the impact is likely minimal given the relatively small number of shares sold compared to the total outstanding shares.

Key Dates